Physician profile
Umar Mahmood
NPI 1396728697
$5,337.99
in general payments reported to CMS, 2019-2025
7 companies · $39.77 in 2025
The $39.77 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,726 · 2023: $1,967 · 2024: $605 · 2025: $39.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,860 · Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,859.86 |
| Food and Beverage | $752.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,525.28 | 2019 | |
| Siemens Medical Solutions USA, INC. | $1,781.13 | 2023-2025 | Biograph Vision 600 (8 Ring/64 Ct), Symbia Pro.Specta Q3, Unique Single Energy Medical Charged Particle Radiation Therapy System |
| Stryker Corporation | $498.00 | 2023 | Augment Injectable |
| Blue Earth Diagnostics | $254.96 | 2024 | |
| Abbott Laboratories | $180.17 | 2019 | |
| Spinal Simplicity, LLC | $77.83 | 2024 | Ha Minuteman G3-R |
| Takeda Pharmaceuticals U.S.A., INC. | $20.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umar Mahmood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.